• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,415.35 231.99
( 0.31%)
Global Indices
Nasdaq
50,311.43 281.08
(0.56%)
Dow Jones
7,466.66 12.69
(0.17%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,466.07 33.73
(0.32%)
Forex
USD-INR
96.70 0.18
(0.19%)
EUR-INR
112.25 0.09
(0.08%)
GBP-INR
129.69 0.32
(0.24%)
JPY-INR
0.61 0.00
(0.25%)

EQUITY - MARKET SCREENER

Astrazeneca Pharma India Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
506820
INE203A01020
319.6
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ASTRAZEN
103.09
21445.38
EPS(TTM)
Face Value()
Div & Yield %
83.21
2
0.37
 

genpharmasec limited
Bharat Forge consolidated net profit declines 17.53% in the March 2026 quarter
May 07,2026
Net profit of Bharat Forge declined 17.53% to Rs 232.57 crore in the quarter ended March 2026 as against Rs 282.00 crore during the previous quarter ended March 2025. Sales rose 17.53% to Rs 4528.04 crore in the quarter ended March 2026 as against Rs 3852.60 crore during the previous quarter ended March 2025.

For the full year,net profit rose 14.72% to Rs 1079.66 crore in the year ended March 2026 as against Rs 941.15 crore during the previous year ended March 2025. Sales rose 11.17% to Rs 16811.65 crore in the year ended March 2026 as against Rs 15122.80 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4528.043852.60 18 16811.6515122.80 11
OPM %17.1717.63 -17.3517.79 -
PBDT745.96653.16 14 2792.542486.51 12
PBT490.87429.40 14 1821.611612.90 13
NP232.57282.00 -18 1079.66941.15 15